Comment on "Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis".
作者信息
Oguz Mustafa, Demirci Murat
机构信息
Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Turkey.
Marmara University Medical School, Istanbul, Turkey.
出版信息
Postepy Kardiol Interwencyjnej. 2025 May 30;21(2):289-290. doi: 10.5114/aic.2025.151709. eCollection 2025 Jun.
Abstract
摘要
相似文献
1
Comment on "Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis".关于“口服曲前列尼尔治疗肺动脉高压的疗效：一项系统评价和荟萃分析”的评论
Postepy Kardiol Interwencyjnej. 2025 May 30;21(2):289-290. doi: 10.5114/aic.2025.151709. eCollection 2025 Jun.
2
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis.靶向前列环素途径的口服疗法治疗肺动脉高压的比较疗效：一项系统评价和网状Meta分析
Vascul Pharmacol. 2024 Mar;154:107280. doi: 10.1016/j.vph.2024.107280. Epub 2024 Feb 1.
3
A Bayesian Network Meta-analysis of Add-on Drug Therapies Specific for Pulmonary Arterial Hypertension.贝叶斯网络荟萃分析肺动脉高压特定附加药物治疗。
Ann Pharmacother. 2020 May;54(5):423-433. doi: 10.1177/1060028019888760. Epub 2019 Nov 18.
4
Practical Considerations for Managing Patients on Tyvaso DPI (Treprostinil Inhalation Powder).管理使用 Tyvaso DPI（曲前列尼尔吸入粉雾剂）患者的实际考量
Pulm Circ. 2025 Jul 3;15(3):e70119. doi: 10.1002/pul2.70119. eCollection 2025 Jul.
5
Pulmonary artery denervation versus conventional therapies for PAH: a systematic review and updated network meta-analysis.肺动脉去神经术与 PAH 常规治疗的比较：系统评价和更新的网络荟萃分析。
ESC Heart Fail. 2024 Oct;11(5):2889-2900. doi: 10.1002/ehf2.14842. Epub 2024 May 23.
6
Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis.靶向治疗慢性血栓栓塞性肺动脉高压的疗效和安全性比较：系统评价和网络荟萃分析。
Can Respir J. 2021 Sep 1;2021:1626971. doi: 10.1155/2021/1626971. eCollection 2021.
7
Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: A systematic review and meta-analysis.脑利钠肽在肺动脉高压患者中的预后价值：系统评价和荟萃分析。
Am Heart J. 2022 Aug;250:34-44. doi: 10.1016/j.ahj.2022.05.006. Epub 2022 May 6.
8
Animal models of pulmonary arterial hypertension: A systematic review and meta-analysis of data from 6126 animals.肺动脉高压动物模型：来自 6126 只动物数据的系统评价和荟萃分析。
Pharmacol Res. 2017 Nov;125(Pt B):201-214. doi: 10.1016/j.phrs.2017.08.003. Epub 2017 Sep 1.
9
Plain language summary: oral treprostinil (Orenitram) for the treatment of pulmonary arterial hypertension (PAH).简明摘要：口服曲前列尼尔（Orenitram）用于治疗肺动脉高压（PAH）。
Future Cardiol. 2025 Jul;21(9):651-661. doi: 10.1080/14796678.2025.2507466. Epub 2025 Jun 17.
10
Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis.口服曲前列尼尔治疗肺动脉高压的疗效：一项系统评价和荟萃分析。
Postepy Kardiol Interwencyjnej. 2024 Sep;20(3):258-263. doi: 10.5114/aic.2024.143558. Epub 2024 Sep 27.
本文引用的文献
1
Dicrotic notch index in pulmonary hypertension: correlation with hemodynamic, echocardiographic and clinical parameters.肺动脉高压中的重搏波切迹指数：与血流动力学、超声心动图及临床参数的相关性
Postepy Kardiol Interwencyjnej. 2024 Dec;20(4):449-454. doi: 10.5114/aic.2024.144977. Epub 2024 Nov 12.
2
Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis.口服曲前列尼尔治疗肺动脉高压的疗效：一项系统评价和荟萃分析。
Postepy Kardiol Interwencyjnej. 2024 Sep;20(3):258-263. doi: 10.5114/aic.2024.143558. Epub 2024 Sep 27.
3
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.初始治疗策略与肺动脉高压长期生存的关系。
Am J Respir Crit Care Med. 2021 Oct 1;204(7):842-854. doi: 10.1164/rccm.202009-3698OC.
4
Selexipag for the Treatment of Pulmonary Arterial Hypertension.塞乐西帕用于肺动脉高压的治疗。
N Engl J Med. 2015 Dec 24;373(26):2522-33. doi: 10.1056/NEJMoa1503184.
Zotero 插件